Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

[1]  R. Roth,et al.  Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier. , 1990, Behavioral neuroscience.

[2]  R. Roth,et al.  Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. , 1990, Brain : a journal of neurology.

[3]  R. Roth,et al.  Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions , 1989, Neuroscience.

[4]  C. Markham,et al.  Deficits in operant behaviour in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1988, Brain : a journal of neurology.

[5]  R. Roth,et al.  Transplantation of fetal neurons in primates. , 1988, Clinical research.

[6]  M. J. Gallagher,et al.  Intracerebral grafting and culture of cryopreserved primate dopamine neurons , 1987, Brain Research.

[7]  R. Roth,et al.  Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF , 1987, Brain Research.

[8]  S. Haber,et al.  Reversal of Parkinsonism by Fetal Nerve Cell Transplants in Primate Brain a , 1987, Annals of the New York Academy of Sciences.

[9]  C. Markham,et al.  Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP , 1987, Brain Research.

[10]  C. Marsden,et al.  Disturbance of sequential movements in patients with Parkinson's disease. , 1987, Brain : a journal of neurology.

[11]  R. Roth,et al.  Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. , 1987, Life sciences.

[12]  S. Haber,et al.  Survival and growth of fetal catecholamine neurons transplanted into primate brain , 1986, Brain Research Bulletin.

[13]  B. Bioulac,et al.  Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data. , 1986, Electromyography and clinical neurophysiology.

[14]  T. Paolo,et al.  Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys , 1986, Brain Research.

[15]  B. A. Brooks,et al.  Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys , 1986, Neuroscience.

[16]  D. Jacobowitz,et al.  Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1986, Life sciences.

[17]  S. Haber,et al.  FETAL NEURONAL GRAFTS IN MONKEYS GIVEN METHYLPHENYLTETRAHYDROPYRIDINE , 1986, The Lancet.

[18]  F. Colpaert,et al.  Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old java monkey [Macaca cynamolgus fascicularis (Raffles)] , 1986, Brain Research Bulletin.

[19]  D. Price,et al.  Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hydroxylase immunocytochemical study in monkey , 1986, Neuroscience.

[20]  C. Marsden,et al.  Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset. , 1986, European journal of pharmacology.

[21]  Y. Stern,et al.  Intellectual changes in patients with MPTP‐induced parkinsonism , 1985, Neurology.

[22]  W. Schultz,et al.  Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism , 1985, Neuroscience Letters.

[23]  H. Pakkenberg,et al.  The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1985, The New England journal of medicine.

[24]  B. Bioulac,et al.  MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study , 1985, Brain Research.

[25]  D. Jacobowitz,et al.  Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. , 1985, Life sciences.

[26]  J. Lockman.  The development of detour ability during infancy. , 1984, Child development.

[27]  H. Weingartner,et al.  Cognitive impairments in Parkinson's disease: Distinguishing between effort-demanding and automatic cognitive processes , 1984, Psychiatry Research.

[28]  C. Rebert,et al.  Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey , 1984, Brain Research.

[29]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Lees,et al.  Cognitive deficits in the early stages of Parkinson's disease. , 1983, Brain : a journal of neurology.

[31]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[32]  R. Mayeux,et al.  Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[33]  A. Björklund,et al.  Functional reactivation of the deafferented neostriatum by nigral transplants , 1981, Nature.

[34]  C. Sladek,et al.  Functional development of grafted vasopressin neurons. , 1980, Science.

[35]  A. Bjo¨rklund,et al.  Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants , 1979, Brain Research.

[36]  B J Hoffer,et al.  Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. , 1979, Science.

[37]  J. Baulu,et al.  Some sampling considerations in the quantitation of monkey behavior under field and captive conditions , 1978, Primates.

[38]  R. Lund,et al.  Transplanted neural tissue develops connections with host rat brain. , 1976, Science.

[39]  B. J. Winer,et al.  Statistical Principles in Experimental Design, 2nd Edition. , 1973 .

[40]  R. Reitan,et al.  Intellectual and cognitive functions in Parkinson's disease. , 1971, Journal of consulting and clinical psychology.

[41]  Seymour Geisser,et al.  Statistical Principles in Experimental Design , 1963 .

[42]  Adele Diamond,et al.  Frontal lobe involvement in cognitive changes during the first year of life. , 1991 .

[43]  R. Roth,et al.  Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys. , 1990, Progress in Brain Research.

[44]  R. Roth,et al.  Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. , 1988, Progress in brain research.

[45]  野原 正弘.  Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset , 1988 .

[46]  S. Haber,et al.  Transplantation of fetal dopamine neurons in primate brain reverses MPTP induced parkinsonism. , 1987, Progress in brain research.

[47]  C. Marsden,et al.  The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. , 1986, Journal of neural transmission. Supplementum.

[48]  A J Cross,et al.  N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism. , 1986, Journal of neural transmission. Supplementum.

[49]  D. Jacobowitz,et al.  Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. , 1984, Psychopharmacology bulletin.

[50]  A. Björklund,et al.  Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries. , 1984, Annual review of neuroscience.

[51]  J. Altmann,et al.  Observational study of behavior: sampling methods. , 1974, Behaviour.

[52]  F. Mcdowell,et al.  Intellectual impairment in Parkinson's syndrome. , 1972, Brain : a journal of neurology.